Dupont Capital Management Corp Denali Therapeutics Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$29.0 - $47.27 $125,280 - $204,206	-4,320 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$42.59 - $55.02 $162,140 - $209,461	-3,807 Reduced 46.84%	4,320 $193,000
Q3 2021 Nov 03, 2021	SELL	$48.48 - $78.23 $193,144 - $311,668	-3,984 Reduced 32.9%	8,127 $410,000
Q2 2021 Jul 30, 2021	BUY	$50.3 - $78.44 $609,183 - $949,986	12,111 New	12,111 $950,000

226

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.